Legend Biotech (LEGN) Income towards Parent Company (2019 - 2025)
Historic Income towards Parent Company for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$38.5 million.
- Legend Biotech's Income towards Parent Company rose 6931.32% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$263.6 million, marking a year-over-year increase of 3904.37%. This contributed to the annual value of -$177026.0 for FY2024, which is 6584.18% up from last year.
- As of Q3 2025, Legend Biotech's Income towards Parent Company stood at -$38.5 million, which was up 6931.32% from -$124.2 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Income towards Parent Company ranged from a high of $26284.0 in Q4 2024 and a low of -$199.1 million during Q2 2023
- Over the past 5 years, Legend Biotech's median Income towards Parent Company value was -$100.9 million (recorded in 2025), while the average stood at -$95.8 million.
- As far as peak fluctuations go, Legend Biotech's Income towards Parent Company plummeted by 3557017.6% in 2022, and later surged by 11814.97% in 2024.
- Over the past 5 years, Legend Biotech's Income towards Parent Company (Quarter) stood at -$88.3 million in 2021, then plummeted by 53.82% to -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then surged by 118.15% to $26284.0 in 2024, then crashed by 146413.35% to -$38.5 million in 2025.
- Its last three reported values are -$38.5 million in Q3 2025, -$124.2 million for Q2 2025, and -$100.9 million during Q1 2025.